James E. Lingeman MD, FACSProfessor of Urology at Indiana University School of Medicine, Co-Director, International Kidney Stone Institute, Indianapolis, Indiana
Dr. Lingeman is well known nationally and internationally for his interest in the area of kidney stone disease and minimally invasive urologic techniques. Dr. Lingeman performed the first percutaneous stone removal procedure in the State of Indiana in 1983 and performed the first ESWL treatment in the United States at Indiana University Health/Methodist Hospital in Indianapolis in 1984. Currently, Dr. Lingeman and Indiana University Health are widely recognized for their expertise in both state-of-the-art techniques for kidney stone removal and also in understanding and preventing kidney stone formation. Dr. Lingeman holds several grants from the National Institutes of Health studying extracorporeal shock wave lithotripsy and kidney stone formation.
In addition to kidney stone disease, Dr. Lingeman is also well known for his work with other minimally invasive urologic techniques. He performed the first laparoscopic nephrectomy in the State of Indiana and also introduced the use of the holmium laser for urolithiasis and benign prostatic hyperplasia (BPH). The first holmium laser prostatectomy (HoLEP) in the United States was performed at Methodist Hospital by Dr. Lingeman in 1998.
Dr. Lingeman is currently Co-Director of the International Kidney Stone Institute. Dr. Lingeman is a Professor of Urology at Indiana University School of Medicine. He is a past president of the Indiana State Urologic Society and past president of the North Central Section of the American Urological Association. Dr. Lingeman is a past president of the Endourology Society. He is a member of the American Association of Genitourinary Surgeons (AAGUS). Dr. Lingeman is the author of over 350 peer review scientific publications.
Dr. Lingeman established a fellowship in stone disease and minimally invasive urology in 1990. He has graduated 24 fellows to date, many of whom hold faculty positions at prominent academic institutions around the world.
DisclosuresDr. Lingeman has no relevant disclosures.
Recent Contributions to PracticeUpdate:
- Effects of MOSES Technology in Holmium Laser Enucleation of the Prostate
- MOSES Technology for Holmium Laser Enucleation of the Prostate
- Predictive Factors of Urinary Incontinence After Holmium Laser Enucleation of the Prostate
- 18 Years of Holmium Laser Enucleation of the Prostate
- Prospective Evaluation of the Learning Curve of Holmium Laser Enucleation of the Prostate
- Optimization of Extracorporeal Shock Wave Lithotripsy Delivery Rates Achieves Excellent Outcomes for Ureteral Stones